Gus Bassani, PharmD, PCCA Chief Scientific Officer, and Daniel Banov, RPh, MS, PCCA Director of Research and Development, join co-hosts Mike De Lisio and Sebastian Denison, RPh, FAARM (candidate), to discuss the anhydrous bases available from PCCA. In this episode, they talk about the versatility of these bases, the technology behind them and why their anhydrous property is so important in the world of pharmacy compounding.